Cite
HARVARD Citation
Numata, T. et al. (2018). Sézary syndrome managed with histone deacetylase inhibitor followed by anti‐CCR4 monoclonal antibody. Clinical and experimental dermatology. pp. 281-285. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Numata, T. et al. (2018). Sézary syndrome managed with histone deacetylase inhibitor followed by anti‐CCR4 monoclonal antibody. Clinical and experimental dermatology. pp. 281-285. [Online].